Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline for Acute Ischemic Stroke with Basilar Artery Occlusion
NCT05512910Phase 4Active, not recruiting
- Sponsor
- Xijing Hospital
- Start
- Mar 2023
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of minocycline in ischemic stroke, sponsored by Xijing Hospital. Started Mar 2023; status: active, not recruiting.
02
Drugs
minocycline
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT05512910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05512910.